Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.01
(
1.02%
)
US TECH 100
26,707.60
(
-0.01%
)
Dow Jones
49,652.14
(
1.62%
)
Brent Oil
110.68
(
0.29%
)
Bitcoin
77,227.40
(
1.18%
)
News Focus
News Focus
Post# of 57817
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gfp927z

Send PM Follow Ignore
Followers 97
Posts 38822
Boards Moderated 89
Alias Born 03/22/2005

gfp927z

Re: haysaw post# 33023

Thursday, 04/01/2010 11:46:08 AM

Thursday, April 01, 2010 11:46:08 AM

Post# of 57817
Haysaw, Unlike RD, ADHD should be much easier to partner. Pivotal ADHD trials are straightforward in design, and ADHD has much broader pharma interest than RD.

Once Cortex has the ADHD trial underway, the share price should start to reflect that reality.






























Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today